|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Limited intertemporal commitment and job design 显示文摘 | Meyer M A Trond E Gaute T | 1996 | Journal of Economic Behavior & Organization1996，31，： | 1 |
| 2 | Career concerns, monetary incentives and job design 显示文摘 | Oddvar M K Trond E O | 2006 | Scandinavian Journal of Economies2006，108，2： | 1 |
| 3 | Carbon mineralization,fungal and bacterial growth,and enzyme activities as affected by contact between crop residues and soil显示文摘 | TROND M BRELSND | 2002 | Biol Fertil Soils2002，3540，： | 1 |
| 4 | Carbon mineralization,fungal and bacterial growth,and enzyme activities as affected by contact between crop residues and soil 显示文摘 | Trond M Henriksen Tor A | 2002 | Biology and Fertility of Soils2002，35，1： | 1 |
| 5 | The Value of ultrasound in predicting autoimmune thyroid disease 显示文摘 | Ole M P Niles P A Trond B L | 2000 | Thyroid2000，10，3： | 1 |
| 6 | Generation of induced pluripotent stem eells from human cord blood using OCT4 and SOX2显示文摘 | ALESSANDRA G NURIA M TROND A | 2009 | Cell Stem Cell2009，5，： | 1 |
| 7 | Fish protein hydrolyzate in starter diets for Atlantic salmon (Salmon salar) fry 显示文摘 | Gerd M B Trond S | 1996 | Aquaculture1996，145，： | 1 |
| 8 | Carbon mineralization, fungal and bacterial growth, and enzyme activities as affected by contact be- tween crop residues and soil显示文摘 | Trond M Hem'iksen Tor A Breland | 2002 | Biology and Fertility of Soils2002，35，： | 1 |
| 9 | Carbon mineralization, fungal and bacterial growth, and enzyme activities as affected by contact between crop residues and soil显示文摘 | Trond M Henriksen Tor A Breland | 2002 | Biology and Fertility of Soils2002，35，1： | 1 |
| 10 | Cloning,pharmacological characterisation and tissue distri- bution of a novel 5-HT4 receptor splice variant,5-HT4 (i) 显示文摘 | Trond Brattelid Ane M Kvingedal Kurt A Krobert | 2004 | Naunyn-Sehmiedeberg''s Arch Ph armaeol2004，369，6： | 1 |
| 11 | Limited intertemporal commitment and job design 显示文摘 | Meyer M A Trond E Gaute T | 1996 | Journal of Economic Behavior & Organization1996，31，： | 1 |
| 12 | Career concerns, monetary incentives and job design 显示文摘 | Oddvar M K Trond E O | 2006 | Scandinavian Journal of Economics2006，108，2： | 1 |
| 13 | Nonleaching Antimicrobial Films Prepared from Surface-Modified Microfibrillated Cellulose 显示文摘 | Martin A Per S Trond M | 2007 | Biomacromolecules2007，8，： | 1 |
| 14 | 对于有症状重度主动脉瓣狭窄且外科手术风险低至中危的患者,是选择经导管还是外科主动脉瓣置换:临床实践指南显示文摘对于有症状重度主动脉瓣狭窄且外科心脏手术风险相对较低的患者,微创操作同直视手术相比孰优孰劣?结合最近的一项临床试验结果,专家组根据3个相关综述文献提出了如下几条建议。 | Per O Vandvik Catherine M Otto Reed A Siemieniuk Rodrigo Bagur Gordon H Guyatt Lyubov Lytvyn Richard Whitlock Trond Vardal David Brieger Bert Aertgeerts Susanna Price Farid Foroutan Michael Shapiro Ray Mertz 郑骏楠 李伟栋 | 2018 | 英国医学杂志中文版2018，21，1： | 0 |
| 15 | patients with inflammatory bowel disease:Mechanisms and possible clinical impact显示文摘BACKGROUND High-dose intravenous iron is an effective treatment option for iron deficiency(ID)or ID anaemia(IDA)in inflammatory bowel disease(IBD).However,treatment with ferric carboxymaltose(FCM)has been associated with the development of hypophosphatemia.AIM To investigate mechanisms behind the development of hypophosphatemia after intravenous iron treatment,and disclose symptoms and clinical manifestations related to hypophosphatemia short-term.METHODS A prospective observational study of adult IBD patients with ID or IDA was conducted between February 1,2017 and July 1,2018 at two separate university hospitals in the southeast region of Norway.Patients received one dose of 1000 mg of either FCM or ferric derisomaltose(FDI)and were followed for an observation period of at least 7 wk.Blood and urine samples were collected for relevant analyses at baseline,week 2 and at week 6.Clinical symptoms were assessed at the same timepoints using a respiratory function test,a visual analogue scale,and a health-related quality of life questionnaire.RESULTS A total of 106 patients was available for analysis in this study.The FCM treatment group consisted of 52 patients and hypophosphatemia was present in 72.5%of the patients at week 2,and in 21.6%at week 6.In comparison,the FDI treatment group consisted of 54 patients and 11.3%of the patients had hypophosphatemia at week 2,and 3.7%at week 6.The difference in incidence was highly significant at both week 2 and 6(P<0.001 and P<0.013,respectively).We observed a significantly higher mean concentration of intact fibroblast growth factor 23(P<0.001),a significant rise in mean urine fractional excretion of phosphate(P=0.004),a significant decrease of 1,25-dihydroxyvitamin D(P<0.001)and of ionised calcium levels(P<0.012)in the FCM-treated patients compared with patients who received FDI.No clinical symptoms could with certainty be related to hypophosphatemia,since neither the respiratory function test,SF-36(36-item short form health survey)or the visual analogue scale scores resulted in significant differences between patients who developed hypophosphatemia or not.CONCLUSION Fibroblast growth factor 23 has a key role in FCM induced hypophosphatemia,probably by inducing loss of phosphate in the urine.Short-term clinical impact of hypophosphatemia was not demonstrated. | Trond Espen Detlie Jonas Christoffer Lindstrøm Marte Eide Jahnsen Elisabeth Finnes Heinz Zoller Bjørn Moum Jørgen Jahnsen | 2021 | World Journal of Gastroenterology2021，27，17： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员